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Introduction
The EuroSCORE II was designed with the purpose of
improving the calibration of the previous additive and
logistic version. This improvement has not been
observed in our patients due to a global underestimation
of mortality.
Objectives
This study is aimed to design a cardiac surgery risk
score to evaluate operative mortality in our patients.
This is defined as in-hospital mortality or mortality by
30 days after the operation for patients discharged from
the hospital.
Methods
Data for all patients undergone heart surgery at the
University Hospital of Salamanca, Spain, between 2001
and 2014 were collected. The data set was divided into a
developmental subset for logistic regression modelling
and a validation subset for model testing. Our results
were compared with EuroSCORE II. Accuracy was
defined with a receiver-operating characteristics analysis
and calibration with a Hosmer-Lemeshow test. Data was
analyzed with SPSS v.22.
Results
In the developmental subset we included 3316 patients
who had undergone cardiac surgery between 2001 and
2010, with 6.5% mortality. We identified predictors of
mortality with x2 and t-Student tests (p < 0.05) and
designed the model using forward logistic regression
based on likelihood ratio statistics. We created a simplified
clinical risk assessment tool derived from the logistic
regression equation which included female sex, age (> 70
years), extracardiac arteriopathy, serum creatinine greater
than 2 mg/dl, previous cardiac surgery, NYHA class IV,
left ventricle ejection fraction lower than 30%, pulmonary
artery pressure greater than 55 mmHg, critical preopera-
tive state, urgent o emergency operation, isolated CABG
and three or more procedures. The validation series
included 1302 patients between 2011 and 2014. Discrimi-
nation assessed with the ROC curve was good with our
model (AUC 0.76) and also with EuroSCORE II (AUC
0.75), though it was poor calibrated in the validation data
(actual mortality: 7.2%, predicted: 5.6%). Good calibration
was found with our model (predicted mortality: 8.3%) with
a non significant Hosmer-Lemeshow test (x2 6.14, p: 0.52).
Conclusions
Differences in our population explain the poor calibra-
tion we found with EuroSCORE II: older and sicker
patients, more women and less isolated CABG are some
of these differences. Any existing model should be tested
to assess calibration in a specific population. Models
derived from local subjects ensure a better performance
if the goal is risk prediction.
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